This content is provided by Chambers. Learn more about our methodology
What the team is known for A prominent firm, actively engaged in representing both issuers and underwriters on a diverse range of capital markets transactions. Highly experienced in handling debt and equity offerings, including IPOs, in the technology and healthcare industries. Particularly skilled at advising on transactions involving high-yield debt securities.
Strengths "We consider them to be one of the very best in the US and we really appreciate their global reach and personalized service," says a client, who adds: "We have always felt, with any lawyer, that they have always been totally focused on our deal, and we will continue to hire them on future transactions."
"They are always at the top of my mind for any complex high-yield questions I may have," says another commentator, who reports: "They have a commercial mindset towards execution and getting a deal done. When there isn’t a way to solve a problem, their team will look for out-of-the-box and one-off unique solutions."
A third source says: "The team is worth every penny," noting: "They are always responsive to our ever-changing needs in the capital markets area. If issues arise, they never have a problem bringing in other professionals to address complex situations or questions."
Work highlights Advised JBS S.A. in eight separate offerings of high-yield notes for a total of $4.7 billion in aggregate principal amount.
Colin Diamond stands out for his extensive representation of issuers and underwriters in complex equity transactions. One client describes him as an "incredibly responsive, top-level public securities lawyer and a great IPO lawyer."
Stuart Bressman is an experienced securities lawyer, who is respected for his work advising on debt and equity offerings in the pharmaceutical and life sciences industries. "He has the unique ability to work at the highest level of this area," according to one commentator, who says: "I'm always pleased to see him on a transaction."